Cantourage Group SE (FRA:HIGH)

Market Cap	72.82M +46.4%
Revenue (ttm)	3.91M +78.0%
Net Income	126.46K +59.5%
EPS	n/a
Shares Out	n/a
PE Ratio	575.88
Forward PE	60.69
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	5.56
Previous Close	5.60
Day's Range	5.56 - 5.56
52-Week Range	2.13 - 6.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Cantourage Group SE

Cantourage Group SE operates as a medical cannabis company in Europe and internationally. The company offers cannabis flowers, extracts, dronabinol, tetrahydrocannabinol, and cannabidiol products. It exports its products. The company distributes its products through pharmacies, wholesalers, and partners. Cantourage Group SE was founded in 2019 and is headquartered in Berlin, Germany.

• Industry: Pharmaceutical Preparations
• Founded: 2019
• Employees: 11
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: HIGH

Financial Performance

In 2025, Cantourage Group SE's revenue was 3.91 million, an increase of 77.97% compared to the previous year's 2.20 million. Earnings were 126,458, an increase of 59.48%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error